U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07195175) titled 'Study of MAR002 in Healthy Men' on Aug. 27.
Brief Summary: Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Study Start Date: Aug. 11
Study Type: INTERVENTIONAL
Condition:
Acromegaly
Intervention:
DRUG: MAR002
subcutaneous injection
DRUG: Placebo
Subcutaneous injection
Recruitment Status: RECRUITING
Sponsor: Marea Therapeutics
Published by HT Digital Content Services with permission from Health Daily Digest....